FDA Inspection 1303412 — Hikma Pharmaceuticals USA INC.
The FDA completed an inspection of Hikma Pharmaceuticals USA INC. on Apr 30, 2026 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 30, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Columbus, OH (United States)